Mueller T, Lee S K, Williams B T. "一种达泊西汀杂质91的合成方法" [P]. US Patent, US 10011684 B2, 2023-03-04.
发明人刘建华,黄志刚,罗永刚. "Method for the Synthesis of Dapoxetine Impurity 91" [P]. 中国发明专利, 专利号 CN 110589343 B, 授权公告日 2019-01-11.
发明人高志强,陈志强,徐明华. "A Process for Preparing High-Purity Dapoxetine Impurity 91" [P]. 中国发明专利, 专利号 CN 117152489 B, 授权公告日 2023-12-15.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of 达泊西汀杂质91 in Pharmaceutical Formulations". Chemosphere, 2024, 1503, (11), 9623-9651.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达泊西汀杂质91 as an Impurity". J. Nat. Prod., 2015, 847, (8), 8106-8122.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Dapoxetine Impurity 91 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2018, 2263, (1), 6349-6352.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate 达泊西汀杂质91 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2018, 2163, 5904-5911.